Cancer Care Plan

Published Studies and Reports Include

• 1. OXIDANTS
  Subject: Oxidants, antioxidants, and the degenerative diseases of aging
  Authors: Ames BN, Shigenaga MK, Hagen TM.
  Publication: Proc Natl Acad Sci 1993;90:7915–22
  
• 2. IP6
  Subject: IP-6: a novel anticancer agent
  Authors: Shamsuddin AM, Vucenik I, Cole KE.
  Publication: Life Sci 1997;61:343–54 [review].
• 3. VITAMIN C
  Subject: Intake of vegetables, fruits, beta-carotene, vitamin C and vitamin supplements and cancer incidence among the elderly: a prospective study
  Authors: Shibata A, Paganini-Hill A, Ross RK, Henderson BE.
  Publication: Br J Cancer 1992;66:673–9
• 4. SELENIUM
  Subject: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin .
  Authors: Clark LC, Combs GF Jr, Turnbull BW, et al.
  Publication: JAMA 1996;276:1957–63
• 5. VITAMIN E
  Subject: Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial.
  Authors: Heinonen OP, Albanes D, Virtamo J, et al.
  Publication: J Natl Cancer Inst 1998;90:440–6.
• 6. ALPHA-LIPOIC ACID
  Subject: Antioxidant action of thioctic acid and dihydrolipoic acid.
  Authors: Kagan V, Khan S, Swanson C, et al.
  Publication: Free Radic Biol Med 1990;9S:15
• 7. GREEN TEA
  Subject: Green tea and cancer chemoprevention.
  Authors: Suganuma M, Okabe S, Sueoka N, et al.
  Publication: Mutat Res 1999;428:339–44
• 8. IP6
  Subject: Suppression of colonic cancer by dietary phytic acid.
  Authors: Graf E, Eaton JW.
  Publication: Nutr Cancer 1993;19:11–9 [review].
• 9. VITAMIN C
  Subject: Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer.
  Authors: Cameron E, Pauling L.
  Publication: Proc Natl Acad Sci USA 1978;75:4538–42
• 10. SELENIUM
  Subject: Selenium
  Authors: Yu B, Wang M, Li D.
  Publication: Chung Hua Wai Ko Tsa Chih 1996;34:50–3
  
• 11. MULTIVITAMINS
  Subject: A cross-sectional study of vitamin intake in postoperative non-small cell lung cancer patients
  Authors: Jatoi A, Daly BD, Kramer G, Mason JB.
  Publication: J Surg Oncol 1998;68:231–6
  
• 12. COENZYME Q10
  Subject: Partial and complete regression of breast cancer in patients in relation to dosage of coenzyme Q10
  Authors: Lockwood K., Moesgaard S., Folkers K.
  Publication: Biochem Biophys Res Comm 1994;199:1504–8.
• 13. LYCOPENE
  Subject: Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy
  Authors: Kucuk O, Sarkar FH, Sakr W, et al.
  Publication: Cancer Epidemiol Biomarkers Prev 2001;10:861–8
• 14. GREEN TEA
  Subject: Anti-metastatic activity of curcumin and catechin.
  Authors: Menon LG, Kuttan R, Kuttan G.
  Publication: Cancer Lett 1999;141:159–65
• 15. GREEN TEA
  Subject: Influence of drinking green tea on breast cancer malignancy among Japanese patients.
  Authors: Nakachi K, Suemasu K, Suga K, et al.
  Publication: Jpn J Cancer Res 1998;89:254–61
• 16. MULTIVITAMINS
  Subject: Nutritional deficiencies in patients receiving cancer chemotherapy.
  Authors: Dreizen S et al.
  Publication: Postgrad Med 1990;87(1):163–70
• 17. ANTIOXIDANTS
  Subject: Cardioprotection in patients undergoing chemo- and/or radiotherapy for neoplastic disease.
  Authors: Wagdi P, Fluri M, Aeschbacher B, et al.
  Publication: Jpn Heart J 1996;37:353–9
• 18. GINGER
  Subject: Oral ingestion of encapsulated ginger and reported self care actions for the relief of chemotherapy-associated nausea and vomiting.
  Authors: Pace JC.
  Publication: Dissertation Abstr Internat 1987;8:3297
• 19. MILK THISTLE
  Subject: Antiproliferative effect of silybin on gynaecological malignancies: Synergism with cisplatin and doxorubicin.
  Authors: Scambia G, De Vincenzo R, Ranelletti FO, et al.
  Publication: Eur J Cancer 1996;32A:877–82
• 20. MILK THISTLE
  Subject: Cisplatin nephrotoxicity and protection by silibinin
  Authors: Gaedeke J, Fels LM, Bokemeyer C, et al.
  Publication: Nephrol Dial Transplant 1996;11:55–62
  
• 21. N-ACETYL CYSTEINE
  Subject: Prophylaxis of ifosfamide toxicity with oral acetylcysteine
  Authors: Holoya PY, Duelge J, Hansen RM, et al.
  Publication: Sem Oncol 1983;10(suppl 1):66–71
  
• 22. N-ACETYL CYSTEINE
  Subject: N-acetyl cysteine (NAC) in preventing nausea and vomiting induced by chemotherapy in patients suffering from inoperable non small cell lung cancer (NSCLC).
  Authors: De Blasio F et al.
  Publication: Chest 1996;110(4, Suppl):103S.
• 23. ZINC
  Subject: A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation
  Authors: Ripamonti C, Zecca E, Brunelli C, et al.
  Publication: Cancer 1998;82:1938–45
• 24. BETA CAROTENE
  Subject: The modifying effect of beta-carotene on radiation and chemotherapy induced oral mucositis.
  Authors: Mills EED.
  Publication: Brit J Cancer 1988;57:416–7
• 25. VITAMIN E
  Subject: Treatment of mucositis with vitamin E during administration of neutropenic antineoplastic agents.
  Authors: Lopez I, Goudou C, Ribrag V, et al.
  Publication: Ann Med Intern [Paris] 1994;145:405–8
• 26. GLUTAMINE
  Subject: Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy.
  Authors: Anderson PM, Schroeder G, Skubitz KM.
  Publication: Cancer 1998;83:1433–9
• 27. GLUTAMINE
  Subject: Oral glutamine in the prevention of chemotherapy-induced gastrointestinal toxicity.
  Authors: Muscaritoli M, Micozzi A, Conversano L, et al.
  Publication: Eur J Cancer 1997;33:319–20
• 28. GLUTAMINE
  Subject: Glutamine, cancer, and its therapy.
  Authors: Klimberg VS, McClellan JL.
  Publication: Am J Surg 1996;172:418–24
• 29. CHAMOMILE
  Subject: Management of oral mucositis during local radiation and systemic chemotherapy: A study of 98 patients.
  Authors: Carl W, Emrich LS.
  Publication: J Prosthet Dent 1991;66:361–9
• 30. ECHINACEA
  Subject: Nonspecific immunostimulation with low doses of cyclophosphamide (LDCY), thymostimulin, and Echinacea purpurea extracts (Echinacin) in patients with far advanced colorectal cancers: Preliminary results
  Authors: Lersch C, Zeuner M, Bauer A, et al.
  Publication: Cancer Invest 1992;10:343–8
  
• 31. GINSENG
  Subject: Eleutherococcus extract treatment for immunostimulation in cancer patients
  Authors: Kupin VI, Polevaya YB, Sorokin AM.
  Publication: Vopr Onkol 1986;32:21–6 [in Russian].
  
• 32. GINSENG
  Subject: Eleutherococcus and Other Biologically Active Modifiers in Oncology.
  Authors: Kupin VJ.
  Publication: Moscow: Medexport, 1984, 21.